Rhopressa passed second phase III today in Glaucoma. First new treatment, not cure/prevention, in 25 years. Aerie Pharma is a company purely devoted to Glaucoma with a short but very successful pipeline that's about to be swimming in cash. They would be a stellar partner for MANF Tx.